What is a key nursing consideration in trigeminal neuralgia?

Master the Medical Surgical Neurosensory Test with our extensive quiz. Dive into multiple choice questions with detailed explanations. Prepare for your exam with confidence!

Multiple Choice

What is a key nursing consideration in trigeminal neuralgia?

Explanation:
Pain control in trigeminal neuralgia centers on using anticonvulsants to calm hyperactive facial nerve firing, and nursing care focuses on starting and monitoring these meds for safety and effectiveness. Anticonvulsants such as carbamazepine or oxcarbazepine are first-line because they reduce the abnormal electrical activity that triggers sharp, episodic facial pain. The nurse should vigilantly assess for adverse effects and interactions, since these drugs can cause dizziness, drowsiness, ataxia, and blurred vision that affect safety, as well as more serious issues like hyponatremia and bone marrow suppression. Regularly monitor labs such as serum sodium and complete blood counts, and be alert to signs of liver enzyme changes or rash. Teach the patient to take the medication exactly as prescribed, avoid abrupt discontinuation, and report any concerning symptoms (e.g., severe rash, unusual bleeding, or persistent fatigue). If a patient cannot tolerate anticonvulsants or experiences inadequate relief, alternatives exist, but they are not the initial approach.

Pain control in trigeminal neuralgia centers on using anticonvulsants to calm hyperactive facial nerve firing, and nursing care focuses on starting and monitoring these meds for safety and effectiveness. Anticonvulsants such as carbamazepine or oxcarbazepine are first-line because they reduce the abnormal electrical activity that triggers sharp, episodic facial pain. The nurse should vigilantly assess for adverse effects and interactions, since these drugs can cause dizziness, drowsiness, ataxia, and blurred vision that affect safety, as well as more serious issues like hyponatremia and bone marrow suppression. Regularly monitor labs such as serum sodium and complete blood counts, and be alert to signs of liver enzyme changes or rash. Teach the patient to take the medication exactly as prescribed, avoid abrupt discontinuation, and report any concerning symptoms (e.g., severe rash, unusual bleeding, or persistent fatigue). If a patient cannot tolerate anticonvulsants or experiences inadequate relief, alternatives exist, but they are not the initial approach.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy